Table 1. Summary statistics for IRASFS Hispanic American participants.
For the descriptive demographic features gender and T2D status the total number of samples evaluated (n) with the number of samples for the trait (all samples) and corresponding percentage are listed. For quantitative demographic feature adiponectin levels and age as well as traits by trait class, the total number of samples evaluated (n), the mean trait value (mean) and standard deviation are listed. For each trait, the results of univariate association with adiponectin are listed as the beta ± standard error (β±SE) with the corresponding p-value.
| Trait Class | Trait | n | all samples | percentage | β±SE | p-value (assoc with adp) |
|---|---|---|---|---|---|---|
| Gender (n, female, %) | 1151 | 672 | 58.4 | 0.28 ± 0.025 | 2.32E-27 | |
| T2D (n, affected, percent total) | 1149 | 126 | 11 | −0.0036 ± 0.044 | 0.934 | |
| n | mean | standard deviation | ||||
| Adiponectin (ug/mL) | 1151 | 13.5 | 7 | NA | ||
| Age (years) | 1151 | 41.1 | 13.9 | 0.0039 ± 0.0010 | 0.0002 | |
| Insulin Sensitivity (SI; ×10−5 min−1 pmol/L) | 964 | 2.21 | 1.88 | 0.24 ± 0.027 | 1.60E-18 | |
| Acute Insulin Response (AIR; pmol/L) | 964 | 775 | 659 | −0.0059 ± −0.0013 | 1.34E-05 | |
| Fasting Glucose (mg/dL) | 1023 | 93.2 | 9.4 | −0.012 ± 0.0014 | 7.44E-18 | |
| Glucose Homeostasis | Fasting Insulin (uU/mL) | 1021 | 14.7 | 10.6 | −0.21 ± 0.019 | 3.09E-26 |
| Body Mass Index (kg/m2) | 1144 | 28.8 | 6.2 | −0.021 ± 0.0023 | 6.57E-19 | |
| Visceral Adipose Tissue (cm2) | 1101 | 110 | 59 | −0.048 ± 0.0048 | 2.66E-22 | |
| Subcutaneous Adipose Tissue (cm2) | 1101 | 338 | 155 | −0.0088 ± 0.0034 | 0.0092 | |
| Adiposity | Visceral Subcutaneous Ratio | 1061 | 0.36 | 0.2 | −0.23 ± 0.026 | 1.19E-17 |
| Triglycerides (mg/dL) | 1146 | 121 | 85 | −0.24 ± 0.022 | 1.38E-27 | |
| Lipids | HDL (mg/dL) | 1148 | 43.6 | 12.9 | 0.85 ± 0.042 | 9.29E-77 |
| Systolic Blood Pressure (mmHg) | 1151 | 118 | 17 | −0.19 ± 0.10 | 0.0598 | |
| Hypertension | Diastolic Blood Pressure (mmHg) | 1151 | 76.1 | 9.8 | −0.64 ± 0.11 | 1.30E-09 |
| C-reactive protein (mg/dL) | 1071 | 3.5 | 4.28 | −0.056 ± 0.012 | 2.58E-06 | |
| PAI-1 (ng/mL) | 1150 | 42.7 | 37.7 | −0.16 ± 0.015 | 5.20E-25 | |
| Inflammation | Fibrinogen (mg/dL) | 1149 | 264 | 62 | −0.023 ± 0.062 | 0.708 |
Footnote: sample sizes range from 964 to 1151 due to incomplete data for some measures. In particular, the FSIGT was not performed in those with diabetes, reducing the sample size for SI and AIR